Issue related to pharmaceutical compounding; Issues related to Domestic manufacturing; Issues related to 340B; Implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience
2025 · 1st Quarter (Jan 1 - Mar 31)
ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY
Filed by JEFFREY J. KIMBELL & ASSOCIATES, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 16, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- JEFFREY J. KIMBELL & ASSOCIATES, INC.
- Filing UUID
- 2990bbf3-37f9-4e91-b7d1-b2b3c0a07426
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.